Therapeutic Implications of Oncogenic Missense HER2 ( ERBB2 ) Mutations in Gastric Adenocarcinoma.
Daniel A KingJulianna J WeielRochelle ReyesMeredith A MillsAntonita ItchonGeorge A FisherJames M FordCarlos J SuarezPublished in: JCO precision oncology (2023)